These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15013284)

  • 1. Transient ischaemic attack associated with the new contraceptive Yasmin.
    Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
    Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep vein thrombosis associated with the new oral contraceptive Yasmin.
    Oo TH
    South Med J; 2009 Sep; 102(9):985-6. PubMed ID: 19668042
    [No Abstract]   [Full Text] [Related]  

  • 3. Yasmin and venous thromboembolism: new case reports.
    López M; Vayá A; Martínez Triguero ML; Contreras MT; Todolí J; Ricart A; Laiz B
    Clin Hemorheol Microcirc; 2009; 42(1):65-9. PubMed ID: 19363241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 6. Yasmin--an oral contraceptive with a new progestin.
    Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages.
    Prescrire Int; 2012 Dec; 21(133):292. PubMed ID: 23373095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral contraceptive-induced acute myocardial infarction.
    Aslan AN; Süygün H; Sivri S; Keleş T
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):499-501. PubMed ID: 27608962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myocardial infarction due to oral contraceptive.
    Kocabay G; Yildiz M; Ozkan M
    Clin Appl Thromb Hemost; 2009; 15(3):364-5. PubMed ID: 19562835
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
    Krunic A; Ciurea A; Scheman A
    J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
    Somma MA
    Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare complication of combined oral contraceptives (COCs): optic neuritis.
    Ege S; Öncül H
    J Obstet Gynaecol; 2021 Feb; 41(2):319-320. PubMed ID: 32037928
    [No Abstract]   [Full Text] [Related]  

  • 16. US panel rules that warnings on two birth control pills be strengthened.
    Lenzer J
    BMJ; 2011 Dec; 343():d8104. PubMed ID: 22167795
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythema multiforme limited to the oral mucosa in a teenager on oral contraceptive therapy.
    Jawetz RE; Elkin A; Michael L; Jawetz SA; Shin HT
    J Pediatr Adolesc Gynecol; 2007 Oct; 20(5):309-13. PubMed ID: 17868899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sinus thrombosis in a healthy female taking oral contraceptives].
    Mogensen SS; Abild-Nielsen A; Bjarnason NH
    Ugeskr Laeger; 2011 Sep; 173(39):2422-3. PubMed ID: 21958487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In brief: FDA warning about drospirenone in oral contraceptives.
    Med Lett Drugs Ther; 2012 Apr; 54(1389):33. PubMed ID: 22538620
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.